Finance

Less Is More In This Market

My Swing Trading Approach Similar to yesterday, I will take a very cautious approach with this market. Less is more in this market and I do not want to rapidly increase my long exposure with such incredible uncertainty. Only under very bullish circumstances today, will I add additional long exposure to my portfolio. Indicators VIX –…

Will ServiceNow Acquire In India Next?

Cloud-based enterprise applications provider ServiceNow (NYSE: NOW) recently announced its first quarter results. As usual, the company continued to outpace market expectations. In fact, given ServiceNow’s performance, the company was recently qualified as one of the “cloud kings” by analyst Jim Cramer. It has been one of my favorites as well. ServiceNow’s Financials ServiceNow saw…

Will ServiceNow Acquire In India Next?

Cloud-based enterprise applications provider ServiceNow (NYSE: NOW) recently announced its first quarter results. As usual, the company continued to outpace market expectations. In fact, given ServiceNow’s performance, the company was recently qualified as one of the “cloud kings” by analyst Jim Cramer. It has been one of my favorites as well. ServiceNow’s Financials ServiceNow saw…

April Employment Growth Picks Up After A Weak Gain In March

US companies added 168,000 workers in April, moderately more than the 138,000 gain in the previous month, which marked the softest increase since last September, the Labor Department reports. The advance kept the annual trend steady, which suggests that moderate growth for the labor market overall remains a reasonable forecast for the near term. Private employment increased…

April 2018 BLS Jobs Situation Is A Little Chaotic

The headline seasonally adjusted BLS job growth was again significantly below expectations. This month’s data is so chaotic – I would not look too deeply at the internals. Analyst Opinion of the BLS Employment Situation The household and establishment surveys were not in sync – which means if you believe the establishment’s survey’s employment growth,…

Celgene (CELG) Beats On Q1 Earnings

Summit, NJ based Celgene Corporation (CELG – Free Report) is a biopharmaceutical company focused on the discovery, development and commercialization of drugs targeting cancer and inflammatory diseases. Celgene’s key growth driver is Revlimid. The company’s portfolio also includes Pomalyst/Imnovid, Abraxane, Otezla, Istodax, Vidaza and Thalomid/Thalidomide. However, Celgene suffered a series of setbacks over the last few months. The company…